|
CN112239466A
|
|
Succinate salt of a selective CDK4/6 inhibitor and crystalline forms thereof
|
|
CN111012749A
|
|
A preparation capable of improving heat stability of tablet and kallidinogenase, and heat stable kallidinogenase tablet and its preparation method
|
|
CN111007253A
|
|
Method for detecting bacterial endotoxin in heparin
|
|
CN110904085A
|
|
Preparation of asparaginase by fermentation method
|
|
CN111004832A
|
|
Method for detecting kallidinogenase
|
|
CN108658966A
|
|
The tartrate and its crystal form of selective CDK9 inhibitor
|
|
CN107328763A
|
|
N NO system and method in a kind of chemical extraction heat energy analytic approach detection Nadroparin Calcium
|
|
CN105176953A
|
|
Pancreatic kallidinogenase purifying process
|
|
CN104774947A
|
|
Fluorescent quantization PCR (polymerase chain reaction) method for detecting gene in heparin crude product
|
|
CN104086674A
|
|
Process for preparing enoxaparin sodium
|
|
CN104086673A
|
|
Preparation process of nadroparin calcium
|
|
CN104045743A
|
|
Method for preparing high-quality dalteparin sodium
|
|
CN104045744A
|
|
Preparation method for dalteparin sodium
|
|
CN103698523A
|
|
Specific anti-rHAP monoclonal antibody, preparation method thereof and kit
|
|
CN103665140A
|
|
Method for separating and purifying annexin V or derivative thereof expressed by escherichia coli
|
|
CN102757516A
|
|
Decoloration method of enoxaparin sodium
|
|
CN102631328A
|
|
Recombinant human antithrombosis protein lyophilized powder injection and preparation method thereof
|
|
CN101063118A
|
|
Method for purification of L-asparaginyl amine enzyme
|
